Common Contracts

2 similar Receivables Financing Agreement contracts by Todos Medical Ltd.

RECEIVABLES FINANCING AGREEMENT dated as of June 19, 2020 among Corona Diagnostics LLC, Todos Medical USA and Todos Medical Ltd., As Borrower, and Toledo Advisors L.L.C., As Lender RECEIVABLES FINANCING AGREEMENT
Receivables Financing Agreement • March 31st, 2022 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • Nevada

This Receivables Financing Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is entered into between Toledo Advisors L.L.C., a Nevada limited liability company with its principal place of business at 641 5th Street, Lakewood, NJ 08701 (together with its successors, the “Lender”), and Corona Diagnostics LLC, a Nevada limited liability company (the “Testing Sub”), Todos Medical USA, a Nevada corporation (the “Holding Company”), and Todos Medical Ltd., an Israeli corporation (the “Parent” and jointly and severally with Testing Sub and the Holding Company, the “Borrower”), each with a mailing address of 45 Wall Street, Suite 920, New York, NY 10005, as of the 19th day of June, 2020 (the “Effective Date”).

RECEIVABLES FINANCING AGREEMENT dated as of June 19, 2020 among Corona Diagnostics LLC, Todos Medical USA and Todos Medical Ltd., As Borrower, and Toledo Advisors L.L.C., As Lender RECEIVABLES FINANCING AGREEMENT
Receivables Financing Agreement • April 21st, 2021 • Todos Medical Ltd. • Surgical & medical instruments & apparatus • Nevada

This Receivables Financing Agreement (as amended, restated, supplemented or otherwise modified, this “Agreement”) is entered into between Toledo Advisors L.L.C., a Nevada limited liability company with its principal place of business at 641 5th Street, Lakewood, NJ 08701 (together with its successors, the “Lender”), and Corona Diagnostics LLC, a Nevada limited liability company (the “Testing Sub”), Todos Medical USA, a Nevada corporation (the “Holding Company”), and Todos Medical Ltd., an Israeli corporation (the “Parent” and jointly and severally with Testing Sub and the Holding Company, the “Borrower”), each with a mailing address of 45 Wall Street, Suite 920, New York, NY 10005, as of the 19th day of June, 2020 (the “Effective Date”).